Overview / Abstract: |
Psoriatic arthritis (PsA), a serious and potentially disabling condition, affects approximately 30% of patients with psoriasis, with the joint involvement often occurring about 10 years after the appearance of skin disease. PsA causes not only physical and functional impairments but also has a negative impact on overall quality of life. While dermatologists have an important role in early detection of PsA, patients often have overlapping treatment needs that require collaborative care between dermatologists and rheumatologists. Recent U.S. Food and Drug Administration (FDA) approvals of several agents for moderate-to-severe PsA have expanded the treatment armamentarium, and the management paradigm continues to evolve. However, PsA continues to be under-recognized, misdiagnosed, and inadequately treated. In this CMEOCast podcast, expert faculty focus on the latest evidence on screening patients for PsA, individualizing treatment that considers patient-reported outcomes (PROs), and using patient-centered approaches for care, with the goal of optimizing patient outcomes. At the end of this CE activity, participants should be able to: The following learning objectives pertain only to those requesting CNE or CPE credit: |
Expiration |
May 04, 2022 |
Discipline(s) |
Nurse Practitioner , Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Podcast |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s) |
Accreditation |
ACCME, ACPE, ABIM/MOC, NCCPA, AANP |
Presenters / Authors / Faculty |
Alexis Ogdie-Beatty, MD, MSCE |
Activity Specialities / Related Topics |
Rheumatology / Arthritis, Pharmacology, Education / Teaching, Dermatology |
Sponsors / Supporters / Grant Providers |
Supported by educational grants from Celgene Corporation and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. |
Keywords / Search Terms |
CME Outfitters Psoriatic Arthritis, Psoriasis, individualized treatment Free CE CME |